Case report | Open | Open Peer Review | Published:
Exiguobacterium sp. A1b/GX59 isolated from a patient with community-acquired pneumonia and bacteremia: genomic characterization and literature review
BMC Infectious Diseasesvolume 17, Article number: 508 (2017)
Bacterial species belonging to the genus Exiguobacterium are facultative anaerobic, non-spore-forming, Gram-positive bacilli, and rarely associated with human infections. Herein, we reported the first case of community-acquired pneumonia (CAP) and bacteremia due to Exiguobacterium spp. in China.
An adult male with severe CAP was hospitalized. The pathogen was isolated from his bloodstream and broncho-alveolar lavage fluid. The correct identification of the micro-organism was achieved using 16S rRNA sequencing, and its antibiotic susceptibility test was performed by microdilution method. The Whole Genome Sequencing (WGS) was used to characterize its genetic features and to elucidate its potential pathogenic mechanisms. Furthermore, its genome sequence was also compared with those of 3 publicly-available Exiguobacterium strains. A PubMed search was performed for further understanding the features of Exiguobacterium infections. Phylogenetic analysis of the 16S rRNA gene sequence showed that the strain GX59 was most closely related to Exiguobacterium AT1b (99.7%). The genome of GX59 was 2,727,929 bp in size, harbouring 2855 putative protein-coding genes, 5 rRNA operons, 37 tRNA genes and 1 tmRNA. The multiple genome comparison of 4 Exiguobacterium strains demonstrated that Exiguobacterium contained 37 genes of secretion systems, including sec, tat, FEA, Type IV Pili and competence-related DNA transformation transporter (Com). Virulence factors of the micro-organism included tlyC, NprR, MCP, Dam, which might play a critical role in causing lethal infection.
The study highlighted the potential pathogenicity of the genus Exiguobacterium for its unique genes encoding various virulence factors and those associated with antibiotic resistance, therefore, its clinical significance should be valued.
The genus Exiguobacterium belongs to the group of coryneform bacteria, firstly described in 1983 by Collins et al. . It is a facultative anaerobic, Gram-positive bacillus. The pathogenic potential of Exiguobacterium spp. seems rather low. To date, only a few cases of bacteremia and skin infection were documented in English literature [2,3,4,5,6]. However, the clinical infection due to the micro-organism might be probably underdiagnosed or unreported, for it tended to be misidentified by routine commercial methods [2,3,4,5,6]. As an emerging pathogen, its pathogenesis should be clarified.
Here, we present a case of community-acquired pneumonia (CAP) and bacteremia due to Exiguobacterium sp. strain AT1b/GX59 in a type 2 diabetes mellitus (T2DM) patient. To the best of our knowledge, this is the first fatal case of CAP and bacteremia due to the micro-organism in a healthy male without serious underlying diseases. In order to generate significant insights into pathogenicity of the micro-organism, its genome was sequenced and compared with 3 Exiguobacterium genomes available in NCBI Genbank database.
On July 28th, 2014, a 51-year-old male with severe pneumonia, acute respiratory distress syndrome was admitted to People’s Hospital of Guangxi Zhuang Autonomous Region at Guangxi, China. He is a farmer living on planting sugarcane and had a history of 8-year T2DM.
At admission, he was febrile (37.8 °C), with a respiratory rate of 60 breaths/min, a pulse rate of 126 beats/min and blood pressure of 165/80 mmHg. He also complained chill, headache, cough, hemoptysis and dyspnea for one day. Physical examination showed that he was in respiratory distress due to chest pain and tightness. Chest CT scan indicated diffuse pulmonary lesions and consolidation. His peripheral leukocyte count was 1.54 × 109/L with 53.9% neutrophils. His blood glucose was badly controlled at 18.0 mmol/L. Results of initial arterial blood gas analyses were: pH 7.42, carbon dioxide pressure (PCO2) 27 mmHg, and oxygen pressure (PO2) 31 mmHg. His liver function tests were within reference ranges; however, his creatinine was 183 μmol/L (reference range 54–106 μmol/L) and urea was 12.7 mmol/L (3.2–7.1 mmol/L). Afterwards, broncho-alveolar lavage fluid (BALF) and 3 sets of blood sample were collected for culture. Furthermore, imipenem combined with voriconazol was empirically administered in an attempt to relieve infection.
Two days after our empirical therapy, his blood pressure dropped to 108/55 mmHg, and arterial blood gas analysis showed: pH 7.26, PCO2 55 mmHg, and PO2 53 mmHg. The marked changes in lung stroma were detected on CT screening. Poor lung compliance, and following alveolar rupture and subcutaneous emphysema brought the patient into a critical condition. On August 1st, the patient fell into a coma and was brought back home by his family members. He died two days later.
Microbial growth was detected in 3 aerobic blood culture bottles obtained through separate needle puncture sites. Direct gram-stain demonstrated Gram-positive, short, and straight rods. Positive blood culture broths were subcultured at 37 °C under 5.0% CO2. The non-hemolytic, gray colonies were observed on blood agar from both blood and BALF cultures, but turned yellow after 48 h, and there was no growth on MacConkey agar, as shown in Fig. 1. The isolate was catalase positive and oxidase negative. Phenotypic identification of the bacteria by the ANC (BioMerieux, France) card yielded poor identification of unidentified organism (isolate Bionumber: 6,521,100,600,035). Antimicrobial susceptibility testing was performed by using micro dilution and E-test method. The MIC results were as follows: susceptible to penicillin (0.064 μg/ml), meropenem (0.064 μg/ml), gentamicin (0.25 μg/ml), ciprofloxacin (0.25 μg/ml), rifampin (0.125 μg/ml), and vancomycin (0.125 μg/ml), but resistant to tetracycline (16 μg/ml), erythromycin (4 μg/ml) and clindamycin (1 μg/ml).
16S rRNA sequencing and phylogenetic analyses
The 16S rRNA sequencing was conducted to identify the pathogen. Other 7 related members of the genus Exiguobacterium available in NCBI Genebank database were included for phylogenetic analyses. The sequence analysis of a 1433 bp segment of the 16S rRNA genes of the organism demonstrated an identity of 99.7% with Exiguobacterium. AT1b (GenBank accession no. NR_074970.1) (Fig. 2).
Whole genome sequencing (WGS)
To elucidate the potential pathogenicity of the micro-organism in current study, we sequenced its whole genome using a whole-genome shotgun strategy based on the Illumina HiSeq platform. The high-quality reads were generated after filtering low-quality ones, adapter contamination and PCR primers by using the software Trimmomatic (version 0.32). De novo assembly was performed with SOAP denovo (version 2.0.1), an empirically-improved memory-efficient short-read de novo assembler, and gaps were closed by Gap Closer (version 1.12). Furthermore, Gene prediction and annotation were carried out by PROKKA pipeline for rapid prokaryotic genome annotation.
This whole-genome shotgun sequencing project has been deposited at DDBJ/ENA/GenBank under the accession GenBank accession no. GCA_001908175.1. WGS generated 6,916,887 bp pair-end reads with read length of 150 bp. A total of 21 scaffolds were assembled, with an N50 size of 539,676 bp, an N90 size of 103,057 bp and the largest scaffold size of 632,933 bp. The GC content of GX59 was 47.49%, similar to that of other Exiguobacterium species. The size of GX59 genome was 2,727,929 bp, containing 2855 putative protein-coding genes, 5 rRNA operons, 37 tRNA genes and 1 tmRNA. The KEGG annotation of the GX59 genome was performed by BlastKOALA, and 52.9% of 2812 entries were annotated (Table 1). The majority of metabolism genes in the genus Exiguobacterium enabled it to survive in various environments. BRITE reconstruction result demonstrated that GX59 strain contained 13 antimicrobial resistance genes, including tetracycline resistance genes (tetB, and efflux pump Tet38), macrolide resistance genes (msrA, vmlR, mef, and vat), aminoglycoside resistance genes (aacC, aac6-I, aacA7, aadA, and aadK), phenicol resistance genes (catA), cationic antimicrobial peptide (CAMP) resistance genes (mprF and fmtC), multidrug resistance efflux pump (abcA and bmrA), and vancomycin resistance modules (vanY and vanW).
The genome sequences of Exiguobacterium sp. AT1b (GenBank accession no. NR_074970.1), E. aurantiacum DSM 6208 (GenBank accession no. NZ_JNIQ01000001.1), and E. acetylicum DSM 20416 (GenBank accession no. NZ_JNIR01000001.1) were collected from NCBI Nucleotide database. The protein sequences of above genomes and that of AT1b/GX59 in current study were collected together and searched against itself via multiparanoid program, based on the Blastp algorithm with the following criteria: identity ≥ 50%, coverage ≥ 50%, BLAST score ≥ 50, and confidence score = 1. Afterwards, unique genes of AT1b/GX59 and those shared by all 4 strains were parsed out from the blast results and annotated by KEGG orthology (KO) identifiers in the web-based server called KAAS (KEGG Automatic Annotation Server: http://www.genome.jp/kegg/kaas/).
Virulence factors related to pathogenicity in Exiguobacterium strain GX59 by WGS
A total of 261 specific genes of Exiguobacterium sp. A1b/GX59 were identified. Moreover, the comparison of general genome features within the 4 Exiguobacterium strains indicated that they shared 1919 core genes, which participated in metabolic, cellular, and genetic information processing, respectively (Fig. 3 and Table 2). Of the 1919 shared genes, 65.5% were annotated with KEGG. A variety of secretion system genes involved in pathogenicity mechanism were also identified. The 4 Exiguobacterium strains possessed 37 genes of secretion systems, encoding two translocons, including sec (secretion), tat (twin-arginine translocation), FEA (flagella export apparatus), FPE (fimbrilin-protein exporter), Type IV Pili and competence-related DNA transformation transporter (com).
Furthermore, 261 specific genes of Exiguobacterium sp. A1b/GX59 were submitted in KAAS, and 24.9% were annotated as hypothetical proteins with the BRITE functional hierarchy. In its genome, a series of unique virulence genes were identified, including tlyC (AT1b/GX59-P-00125 k03699) encoding hemolysin, a type of membrane-damaging toxin, NprR (AT1b/GX59-P-01697 k20480) encoding a quorum-sensing receptor, mcp (methyl accepting chemotaxis proteins) (AT1b/GX59-P-01386 k03406) and Dam (DNA adenine methylase) (AT1b/GX59-P-01413 k06223). Moreover, in secretion systems, Exiguobacterium sp. A1b/GX59 encompassed an extra gene SecDF, which played a role as a chaperone facilitating the translocation of L. monocytogenes virulence factors during infection .
The clinical characterizations of Exiguobacterium species isolated previously from different infectious samples were listed in Table 3 [2,3,4,5,6]. As documented, most infections due to Exiguobacterium spp. had underlying diseases, such as liver cirrhosis , intravenous drug abuse and multiple myeloma . However, the patient in present study was in a generally healthy condition, though he suffered from T2DM. Although a male patient infected by the micro-organism was previously healthy, different from our patient, he had only an ulcer on a finger with a painful black eschar rather than systematic infection . Bacteria of the genus Exiguobacterium distribute extensively and have been isolated from markedly diverse sources, including water, the rhizosphere of plants, and the environment of food processing plants . The patient in current study was a farmer living on processing plants in humid climate of South China. Considering his early clinical symptoms, inhalation of the micro-organism might be a possible portal of entry of his pneumonia .
The literature review demonstrated that Exiguobacterium were rarely isolated as human pathogen. Furthermore, it is difficult to identify Exiguobacterium spp. based on traditional biochemical method. Almost all reported infective strains of this genus were misidentified when the commercial biochemical system was used, including API Coryne kit/VITEK 2 Compact system (Bio-Mérieux, France), and Becton Dickinson Diagnostic Systems [2,3,4,5,6]. Furthermore, Matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) analysis is presently becoming a routinely used tool in many microbiology laboratories, and might be used in identifying the genus Exiguobacterium in future , however, in our study, the strain GX59 was identified as Exiguobacterium aurantiacum 290RLT with its score as 1.547 by using MALDI-TOF (Bruker Daltonics, MALDI Biotyper 3.1 software, 2371 species and 5989 entries included).
In current study, the pathogen could not be identified using ANC card of VITEK 2 system, and was confirmed as Exiguobacterium AT1b by 16s rRNA sequencing only in retrospective analysis. Exiguobacterium AT1b was initially isolated from a slightly alkaline, highly carbonate, and hot spring water sample from Yellowstone National Park , and had never documented to be isolated clinically. Therefore, the in-depth analysis of the Exiguobacterium sp. AT1b/GX59 isolate in present study might elucidate the pathogenicity of this environmental saprophytic micro-organism. Moreover, the comparison study of the genomes of the strain GX59 and other Exiguobacterium spp. might then shed light on the pathogenicity of the microorganism. The publicly-available genomes of Exiguobacterium spp. were mostly isolated from environment. Through ortholog gene analysis, it was reasonably to speculate that several following genetic characteristics were closely related to the pathogenicity of current GX59 strain. Firstly, secretion systems identified in the strain might be involved its pathogenicity. Desvaux M  suggested to use the terms sec, tat, FEA, and FPE in translocation systems across the cytoplasmic membrane of both Gram-positive and -negative bacteria. The above 4 Exiguobacterium strains possessed 37 genes of secretion systems, encoding two translocons, including sec, tat, FEA, and competence-related DNA transformation transporter (Com). In pathogenic Gram-positive bacteria, the vast majority of proteins were exported out of cytosol by conserved general sec system  or, by tat system . Other studies discovered Com proteins were required for internalization of extracellular DNA [13, 14]. Taken together, Exiguobacterium had the ability to export toxins to exert its full virulence and to uptake DNA to acquire a variety of virulence and resistance traits. Secondly, a series of unique virulence genes identified in the GX59 strain genome might explain its high virulence. For example, the hemolysin encoded by the gene tlyC was taken as a virulence factor in a variety of Gram-positive infectious bacteria. Carvalho E  suggested that the protein tlyC was not directly involved in hemolysis, but contributed to binding of Leptospira to extracellular matrix (ECM) during host infection. The non-hemolytic GX59 strain in present study contained tlyC genes, in consistent with Carvalho E’s finding . Moreover, NprR, as a major transcriptional regulator, was documented to belong to RNPP family of quorum-sensing (QS) receptors, a group of intracellular regulators activated directly by signaling oligopeptides in Gram-positive bacteria . It might control sporulation and necrotrophic properties, ensuring survival and dissemination of the bacteria in clinical infections by feeding on host proteins . Another pathogenetic gene uniquely detected in the GX59 strain was mcp, which got involved in virulence, motility, and biofilm formation of bacteria , possibly performing a potential function in invasive infections. Furthermore, Dam mediated the methylation of adenine in the 5′-GATC-3′ sequence shortly after DNA replication, and was implicated as a virulence factor in bacterial pathogenesis. As documented previously, Dam methylation was required for efficient biofilm production in Salmonella enterica serovar enteritidis . Dam was also crucial in modulating the pathogenicity of K. pneumoniae genotype K1 . The Dam gene identified in the GX59 strain might participate in its invasiveness during infection. Finally, apart from the virulence factors unique in the AT1b/GX59 strain, other common virulence factors might be involved in severe infection. For, example, the GX59 strain harboured an extra gene SecDF, which played a role as a chaperone that facilitates the translocation of L. monocytogenes virulence factors during infection . Deletion of secDF resulted in reduced virulence and motility Bacillus cereus ATCC 14579 . Taken together, the severe CAP and following bacteriemia in our patient was possibly explained by the high pathogenicity due to the above-identified virulence genes.
Except for high pathogenic genes, Exiguobacterium spp. also harboured some antimicrobial resistance genes, including tetracycline resistance genes, macrolide resistance genes, aminoglycoside resistance genes, phenicol resistance genes, cationic antimicrobial peptide, multidrug resistance efflux pumps (abcA and bmrA), and vancomycin resistance modules (vanY, vanW). Accordingly, although the strain remained susceptible, it would easily become resistant to many antibiotics. Generally, timely antibiotic therapy often resulted in a favorable outcome in the clinical infections due to the microorganism [2, 3, 5, 6]. However, in current study the isolate was susceptible to the antibiotics used, e.g. meropenem and ciprofloxacin, but the patient died of deteriorated infection. This might be explained by the reasons as follows. The pathogen was not identified timely, the appropriate antibiotic therapy failed to take, and furthermore, the rapidly-deteriorated severe acute type 2 respiratory failure caused his death.
In summary, the Exiguobacterium sp. AT1b/GX59 strain in current study is equipped with a variety of factors that facilitate its adaptation to a pathogenic lifestyle, such as hemolysin, secretion systems, chemotaxis proteins, and antibiotic resistance genes. The Exiguobacterium sp., as a potential pathogen, should attract more attention.
broncho-alveolar lavage fluid
type 2 diabetes mellitus
Whole Genome Sequencing
Collins MD, Lund BM, JAE F, Schleifer KH. Chemotaxonomic study of an alkalophilic bacterium, Exiguobacterium aurantiacum gen. Nov., sp. nov. J Gen Microbiol. 1983;129:2037–42.
Cheng A, Liu C-Y, Tsai H-Y, Hsu M-S, Yang C-J, Huang Y-T, Liao C-H, Hsueh P-R. Bacteremia caused by Pantoea agglomerans at a medical center in Taiwan, 2000–2010. J Microbiol Immunol Infect. 2013;46(3):187–94.
Keynan Y, Weber G, Sprecher H. Molecular identification of Exiguobacterium acetylicum as the aetiological agent of bacteraemia. J Med Microbiol. 2007;56(4):563–4.
Tena DMN, Casanova J, García JL, Román E, Medina MJ, Sáez-Nieto JA. Possible Exiguobacterium sibiricum skin infection in human. Emerg Infect Dis. 2014;20(12):2178–9.
Kenny FXJ, Millar BC, McClurg RB, Moore JE. Potential misidentification of a new Exiguobacterium sp. as Oerskovia xanthineolytica isolated from blood culture. Br J Biomed Sci. 2006;63(2):86.
Pitt TL, Malnick H, Shah J, Chattaway MA, Keys CJ, Cooke FJ, Shah HN. Characterisation of Exiguobacterium aurantiacum isolates from blood cultures of six patients. Clin Microbiol Infect. 2007;13(9):946–8.
Tamar Burg-Golani YP, Rabinovich L, Sigal N, Paz RN, Herskovitsa AA. Membrane chaperone SecDF plays a role in the secretion of listeria monocytogenes major virulence factors. J Bacteriol. 2013;195(23):5262–72.
Vishnivetskaya TAKS, Tiedje JM. The Exiguobacterium genus: biodiversity and biogeography. Extremophiles : life under extreme conditions. 2009;13(3):541–55.
Vishnivetskaya TA, Lucas S, Copeland A, Lapidus A, Glavina del Rio T, Dalin E, Tice H, Bruce DC, Goodwin LA, Pitluck S, et al. Complete genome sequence of the thermophilic bacterium Exiguobacterium sp. AT1b. J Bacteriol. 2011;193(11):2880–1.
Desvaux M, Hebraud M, Talon R, Henderson IR. Secretion and subcellular localizations of bacterial proteins: a semantic awareness issue. Trends Microbiol. 2009;17(4):139–45.
Fagan RP, Fairweather NF. Clostridium Difficile has two parallel and essential sec secretion systems. J Biol Chem. 2011;286(31):27483–93.
Goosens VJ, Monteferrante CG, van Dijl JM. The tat system of gram-positive bacteria. Biochim Biophys Acta. 2014;1843(8):1698–706.
Inamine GS, Dubnau D. ComEA, a Bacillus Subtilis integral membrane protein required for genetic transformation, is needed for both DNA binding and transport. J Bacteriol. 1995;177(11):3045–51.
Muschiol S, Balaban M, Normark S, Henriques-Normark B. Uptake of extracellular DNA: competence induced pili in natural transformation of Streptococcus Pneumoniae. BioEssays. 2015;37(4):426–35.
Carvalho E, Barbosa AS, Gomez RM, Cianciarullo AM, Hauk P, Abreu PA, Fiorini LC, Oliveira ML, Romero EC, Goncales AP, et al. Leptospiral TlyC is an extracellular matrix-binding protein and does not present hemolysin activity. FEBS Lett. 2009;583(8):1381–5.
Perchat S, Talagas A, Poncet S, Lazar N, Li de la Sierra-Gallay I, Gohar M, Lereclus D, Nessler S. How quorum sensing connects sporulation to Necrotrophism in bacillus thuringiensis. PLoS Pathog. 2016;12(8):e1005779.
Choi Y, Kim S, Hwang H, Kim KP, Kang DH, Ryu S. Plasmid-encoded MCP is involved in virulence, motility, and biofilm formation of Cronobacter sakazakii ATCC 29544. Infect Immun. 2015;83(1):197–204.
Aya Castaneda Mdel R, Sarnacki SH, Noto Llana M, Lopez Guerra AG, Giacomodonato MN, Cerquetti MC. Dam methylation is required for efficient biofilm production in Salmonella enterica serovar Enteritidis. Int J Food Microbiol. 2015;193:15–22.
Voros A, Simm R, Slamti L, McKay MJ, Hegna IK, Nielsen-LeRoux C, Hassan KA, Paulsen IT, Lereclus D, Okstad OA, et al. SecDF as part of the sec-translocase facilitates efficient secretion of Bacillus Cereus toxins and cell wall-associated proteins. PLoS One. 2014;9(8):e103326.
This study was partially supported by Civil Aviation General Hospital Research Funds (Grant no. 2014001) and the Science and Technology Program of Tianjin, China (No.13ZCZDSY02500).
Availability of data and materials
The Whole Genome Shotgun project of Exiguobacterium sp. AT1b/GX59 in current study has been deposited at DDBJ/ENA/GenBank under the accession MOEL00000000. (https://www.ncbi.nlm.nih.gov/nuccore/MOEL00000000).
Ethics approval and consent to participate
The institutional review boards at the Civil Aviation General Hospital approved the study protocol.
Consent for publication
Written informed consent was obtained from the patient’s direct relative for publication of this study. A copy of the written consent is available for review by the Editor of this journal.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.